European Journal of Cancer
Volume 39, Issue 9 , Pages 1234-1241 , June 2003

Intrinsic variability in the detection of micrometastases in lymph nodes for re-staging of colorectal cancer: effect of individual markers and tissue samples

  • M Salto-Tellez

      Affiliations

    • Department of Pathology, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260, Singapore2
    • Molecular Diagnosis Centre, Department of Laboratory Medicine, National University Hospital, 5 Kent Ridge Road, Singapore 119074, Singapore
    • Both these authors contributed equally to this paper.
    • ,
  • S.L Kong

      Affiliations

    • Department of Pathology, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260, Singapore2
    • Both these authors contributed equally to this paper.
    • ,
  • A.P.K Leong

      Affiliations

    • Department of Surgery, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260, Singapore
    • ,
  • E.S.C Koay

      Affiliations

    • Department of Pathology, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260, Singapore2
    • Molecular Diagnosis Centre, Department of Laboratory Medicine, National University Hospital, 5 Kent Ridge Road, Singapore 119074, Singapore
    • Corresponding Author InformationCorresponding author. Tel.: +65-6772-4564; fax: 65-6778-0671

Received 10 July 2002 ,Accepted 6 January 2003.

References 

  1. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al.  Micrometastases and survival in stage II colorectal cancer. N. Engl. J. Med. 1998;339:223–228
  2. Sloane JP. Molecules and micrometastases. Lancet. 1995;345:1255–1256
  3. Bustin SA, Dorudi S. Molecular assessment of tumor stage and disease recurrence using PCR-based assays. Mol. Med. Today. 1998;4:389–396
  4. Cutait R, Alves VAF, Lopes LC, et al.  Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis. Colon Rectum. 1991;34:917–920
  5. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer. 1994;73:563–569
  6. Mori M, Mimori K, Inoue H, et al.  Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995;55:3417–3420
  7. Waldman SA, Cagir B, Rakinic J, et al.  Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer. Dis. Colon Rectum. 1998;41:310–315
  8. Cagir B, Gelmann A, Park J, et al.  Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer. Ann. Intern. Med. 1999;131:805–812
  9. Futamura M, Takagi Y, Koumura H, et al.  Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. J. Surg. Oncol. 1998;68:34–40
  10. Funaki NO, Tanaka J, Ohshio G, Onodera H, Maetani S, Imamura M. Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients. Br. J. Cancer. 1998;77:1327–1332
  11. Markman M. Basic Cancer Medicine. Philadelphia: WB Saunders; 1997; [pp. 78–79]
  12. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J. Clin. Oncol. 1994;12:725–729
  13. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins (Patterns of expression in normal epithelial, tumor and cultured cells). Cell. 1982;31:11–24
  14. Franke WW, Moll R. Cytoskeletal components of lymphoid organs. Differentiation. 1987;36:145–163
  15. Moll R, Schiller DL, Franke WW. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with un-usual properties and expression patterns. J. Cell Biol. 1990;111:567–580
  16. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am. J. Pathol. 1992;140:427–447
  17. Moll R, Zimbelmann R, Goldschmidt MD, et al.  The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation. 1993;53:75–93
  18. Cianchi F, Palomba A, Boddi V, et al.  Lymph node recovery from colorectal tumor specimens (recommendation for a minimum number of lymph nodes to be examined). World J. Surg. 2002;26:384–389
  19. Guan RJ, Van Dam J. Molecular detection of micrometastases (science on stage [Review]). Am. J. Gastroenterol. 1999;94:3062–3064
  20. Dorubi S, Kinrade E, Marshall NC, Feakins R, William NS, Bustin SA. Genetic detection of lymph node micrometastases in patients with colorectal cancer. Br. J. Surg. 1998;85:98–100
  21. Merrie AEH, Yun K, McCall JL. Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer [Discussion]. N. Engl. J. Med. 1998;339:1642
  22. Ghossein RA. [Discussion]. N. Engl. J. Med. 1998;339:1642
  23. Mitas M, Mikhitarian K, Walters C, et al.  Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int. J. Cancer. 2001;93:162–171
  24. Carrithers SL, Barber MT, Biswas S, et al.  Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues. Proc. Natl. Acad. Sci. USA. 1996;93:14827–14832
  25. Evans H, Sillibourne J. Detection of the Bcr-Abl gene in CML/ALL patients. Promega Notes Magazine. 1996;57:21–23

PII: S0959-8049(03)00231-4

doi: 10.1016/S0959-8049(03)00231-4

European Journal of Cancer
Volume 39, Issue 9 , Pages 1234-1241 , June 2003

Article Tools

* Image Usage & Resolution